Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
Abstract Peripheral blood is gaining prominence as a noninvasive alternative to tissue biopsy to develop biomarkers for glioblastoma (GBM); however, widely utilized blood-based biomarkers in clinical settings have not yet been identified due to the lack of a robust detection approach. Here, we descr...
Main Authors: | Dan Qi, Yiqun Geng, Jacob Cardenas, Jinghua Gu, S. Stephen Yi, Jason H. Huang, Ekokobe Fonkem, Erxi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-022-00348-3 |
Similar Items
-
Identification of a panel of genes as a prognostic biomarker for glioblastomaResearch in context
by: Fengfei Wang, et al.
Published: (2018-11-01) -
Management of Autoimmune Status Epilepticus
by: Batool F. Kirmani, et al.
Published: (2018-05-01) -
Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
by: Guangrong Lu, et al.
Published: (2019-01-01) -
Global transcriptomic analyses of Salmonella enterica in Iron-depleted and Iron-rich growth conditions
by: Bijay K. Khajanchi, et al.
Published: (2019-06-01) -
Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis
by: Jiabin Wang MD, et al.
Published: (2022-05-01)